查看購物車
  • English
  • Japanese
  • Korean
全球先進療法（老化與健康）市場：按產品類型、應用、分銷管道和地區/國家分類（2025-2035 年）
市場調查報告書
商品編碼
2027382

全球先進療法（老化與健康）市場：按產品類型、應用、分銷管道和地區/國家分類（2025-2035 年）

Advanced Therapeutics (Aging and Wellness) Market - A Global and Regional Analysis: Focus on Product Type, Application Type, Distribution Channel, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 146 Pages | 商品交期: 1-5個工作天內

價格

這份報告可以在一個工作天內送達。

全球先進療法（抗衰老與健康）市場：簡介

2024 年全球先進療法（老化與健康）市場規模為 1,548.9 億美元，但預計將大幅成長，到 2035 年將飆升至 2,753.5 億美元，並且從 2025 年到 2035 年的複合年成長率將達到 5.51%。

關鍵市場統計數據
預測期 2025-2035
2025年市場規模 1610.1億美元
2035 年預測 2753.5億美元
複合年成長率 5.51%

市場概覽

全球先進療法（抗衰老與健康）市場是預防醫學領域一個系統化且快速發展的細分市場，專注於健康老齡化、功能性長壽以及維持持續的生理功能。該市場涵蓋臨床定位的營養配方、功能性生物活性成分以及基於通路、針對代謝、認知、肌肉骨骼、免疫和心血管系統等與老齡化相關的變化而製定的補充策略。人口老化、預期壽命延長以及慢性代謝和退化性疾病負擔日益加重，推動了市場從被動治療轉向預防性健康管理。同時，老化生物學和營養科學的進步正在增強靶向、以結果為導向的配方的循證基礎，使其與臨床相關的健康框架更加契合。消費者對功效、透明度和品質的日益關注，以及對增強肌肉功能、代謝健康和認知韌性的解決方案的需求不斷成長，正在進一步加速市場成長。

對產業的影響

先進療法（抗衰老和健康）市場的演變正從根本上改變整個醫療保健和營養保健品行業的結構，推動著行業向預防性和營養主導干涉措施的轉變。產業參與者日益關注實證產品開發、精準配方和先進遞送技術，以提高生物利用度和功能性療效。這種轉變正在推動臨床研究、原料創新和消費者健康解決方案之間的整合，同時也提升了監管合規和品質標準化的重要性。在商業性，受老化和健康意識增強人群需求成長的驅動，蛋白質補充劑、微量營養素組合和生物活性化合物市場正經歷強勁成長。此外，新興市場機會的增加以及對永續性和潔淨標示產品日益成長的興趣，正迫使企業實現產品組合多元化並採取區域性策略。整體而言，市場正朝著更結構化、實證且擴充性的模式發展，將對醫療保健服務、產品創新和全球健康生態系統產生長期影響。

按產品類型分類，功能性營養品細分市場正在推動市場成長。

2024年，功能性營養品在產品類型中佔了最大的市場。這主要是因為功能性營養品面向最廣泛的消費群，從健康人群到尋求預防性保健的老年人均有涵蓋。與相對小眾、以提升運動表現為導向的運動/活力營養品和治療性營養品（後者更注重臨床應用，通常僅限於特定疾病）不同，功能性營養品介於健康管理和日常保健之間。這包括維生素、礦物質和補充劑等廣泛銷售的產品，這些產品能夠增強認知功能和免疫力，消費者經常食用，也很容易透過零售和電商管道購買。

從應用領域來看，能量、耐力和積極老化是推動市場發展的關鍵因素。

2024年，能量、耐力和積極老化領域佔市場主導。這一主導地位源自於其與老年人最普遍、最持久的需求直接契合：維持日常機能、活力和獨立生活能力。與通常針對特定目標或狀況（例如體重管理、荷爾蒙平衡調節和肌肉維持）的應用不同，能量、耐力和積極老化解決方案適用於更廣泛的人群，從健康人群到那些體力和身體機能出現早期或逐漸下降的人群。該領域還涵蓋了各種日常常用產品，尤其是在功能性營養領域，例如支持能量代謝和整體健康的維生素、礦物質、微量營養素和細胞健康補充劑。此外，隨著預防醫學和長壽保健理念的轉變，消費者不再等到出現臨床問題才採取行動，而是更加重視保持充沛的精力、清晰的認知能力和積極的生活方式。因此，以活力和積極老化為目標的產品憑藉高滲透率、持續的每日攝取量和廣泛的適用性，獲得了最大的市場佔有率。

從地區來看，北美市場處於領先地位。

從區域來看，北美市場主導地位，預計在2024年佔最大市場佔有率，並在整個預測期內保持這一地位。這一主導地位主要得益於高度發展的醫療保健和生命科學生態系統、消費者對健康的高度重視（尤其關注預防醫學和長壽），以及高於其他地區的人均醫療費用支出。特別是美國，它是全球老化科學創新中心，Start-Ups了許多生技公司、長壽相關新創公司和營養保健品公司。此外，該地區受益於有利的人口結構、較高的可支配收入以及積極主動的健康管理文化轉變，使得循證、高品質的健康解決方案在老年人群中得到廣泛認可。

本報告檢視了全球先進療法（老化和健康）市場，總結了關鍵趨勢、市場影響因素、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

摘要整理

範圍和定義

第1章 市場：產業展望

  • 市場概覽
  • 產品基準測試
  • 監管狀態/合規性
    • 美國
    • 歐洲
    • 亞太地區
  • 主要趨勢
    • 從被動醫療保健轉變為預防性自我護理補充劑的結構性。
    • 抗衰老和保健品領域向先進輸送技術的過渡
  • 抗衰老和健康新治療方法
  • 市場動態
    • 影響分析
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 產品類型

  • 產品類型：摘要
  • 運動營養
    • 蛋白質補充劑
    • 胺基酸和恢復補充劑
    • 提升運動表現和補充能量的補充劑
  • 功能營養
    • 促進新陳代謝和體重管理的補充劑
    • 荷爾蒙支持補充劑
    • 維生素、礦物質和微量營養素補充劑
  • 治療性營養

第3章 應用

  • 用途：摘要
  • 維持肌肉力量、肌肉量和活動能力
  • 能源、耐力、積極老化
  • 體重管理和代謝健康
  • 支持荷爾蒙平衡
  • 其他

第4章 分銷管道

  • 分銷管道：概述
  • 零售
  • 網路市集
  • 直接向消費者銷售
  • 其他

第5章 區域

  • 區域：概要
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 威脅市場的因素
    • 國家

第6章：競爭標竿分析與公司概況

  • 關鍵策略與企業發展：按公司分類
    • 夥伴關係、合作與業務拓展
    • 新產品
  • 公司簡介
    • Herbalife Ltd.
    • Glanbia plc
    • Health and Happiness (H&H) International Holdings Limited
    • Archer-Daniels-Midland Company
    • Abbott Laboratories
    • Nestle SA (Nestle Health Science)
    • Amway Corp
    • Gainful Inc.
    • Iovate Health Sciences International Inc.
    • Nar Labs, Inc.
    • Vitabiotics Ltd.
    • Thorne HealthTech
    • NOW Foods
    • RBK Nutraceuticals Pty Ltd
    • Elysium Health

第7章：調查方法

Product Code: BHL3656SA

This report can be delivered within 1 working day.

Global Advanced Therapeutics (Aging and Wellness) Market Industry Overview

The global advanced therapeutics (aging and wellness) market, initially valued at $154.89 billion in 2024, is projected to witness substantial growth, surging to $275.35 billion by 2035, marking a remarkable compound annual growth rate (CAGR) of 5.51% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$161.01 Billion
2035 Forecast$275.35 Billion
CAGR5.51%

Market Introduction

The global advanced therapeutics (aging and wellness) market represents a structured and rapidly evolving segment within preventive healthcare, focused on enabling healthy aging, functional longevity, and sustained physiological performance. It encompasses clinically positioned nutritional formulations, functional bioactives, and pathway-aligned supplementation strategies targeting age-associated changes across metabolic, cognitive, musculoskeletal, immune, and cardiovascular systems. Driven by expanding aging populations, increasing life expectancy, and the rising burden of chronic metabolic and degenerative conditions, the market is witnessing a shift from reactive treatment toward proactive health management. At the same time, advancements in aging biology and nutrition science are strengthening the evidence base for targeted, outcome-oriented formulations, supporting greater alignment with clinical-adjacent health frameworks. Growing consumer awareness around efficacy, transparency, and quality, along with increasing demand for solutions addressing muscle preservation, metabolic health, and cognitive resilience, is further accelerating market expansion.

Industrial Impact

The evolution of the advanced therapeutics (aging and wellness) market is significantly reshaping the broader healthcare and nutraceutical industries by driving a transition toward preventive, nutrition-led interventions. Industry players are increasingly focusing on science-backed product development, precision formulations, and advanced delivery technologies to enhance bioavailability and functional outcomes. This shift is fostering greater integration between clinical research, ingredient innovation, and consumer health solutions, while also increasing the importance of regulatory compliance and quality standardization. Commercially, the market is witnessing strong growth in protein-based supplements, micronutrient combinations, and bioactive compounds, supported by expanding demand across aging and health-conscious populations. Additionally, rising opportunities in emerging markets and the growing emphasis on sustainability and clean-label products are prompting companies to adopt diversified portfolios and region-specific strategies. Overall, the market is moving toward a more structured, evidence-driven, and scalable model, with long-term implications for healthcare delivery, product innovation, and global wellness ecosystems.

Market Segmentation:

Segmentation 1: By Product Type

  • Active/Sports Nutrition
  • Functional Nutrition
  • Therapeutic Nutrition

Functional Nutrition Segment to Dominate the Advanced Therapeutics (Aging and Wellness) Market (by Product Type)

In 2024, the functional nutrition segment accounts for the largest share of the global advanced therapeutics (aging and wellness) market. This is primarily due to functional nutrition, which caters to the broadest consumer base, spanning both healthy individuals and aging populations seeking preventive health benefits rather than condition-specific treatment. Unlike sports/active nutrition, which is relatively niche and performance-driven, or therapeutic nutrition, which is more clinically targeted and often restricted to specific disease conditions, functional nutrition sits at the intersection of wellness and everyday health. It includes widely adopted products such as vitamins, minerals, and cognitive or immunity-boosting supplements, among others, all of which have high consumption frequency and accessibility across retail and e-commerce channels.

Segmentation 2: By Application Type

  • Muscle Strength, Mass, and Mobility Preservation
  • Energy, Endurance, and Active Aging
  • Weight Management and Metabolic Health
  • Hormonal Balance Support
  • Others

Energy, Endurance, and Active Aging to Dominate the Advanced Therapeutics (Aging and Wellness) Market (by Application Type)

The global advanced therapeutics (aging and wellness) market (by application type) was dominated by energy, endurance, and active aging segment in 2024. This dominance is driven by its direct alignment with the most universal and continuous need of the aging population, which is maintaining daily functionality, vitality, and independence. Unlike applications such as weight management, hormonal balance, or muscle preservation that are often pursued for specific goals or conditions, energy, endurance, and active aging solutions are relevant across a much broader population base, including both healthy individuals and those experiencing early or gradual declines in stamina and physical resilience. This segment also captures a wide range of high-frequency, everyday-use products, particularly within functional nutrition, such as vitamins, minerals, micronutrients, and cellular health supplements that support energy metabolism and overall well-being. In addition, the growing shift toward preventive and longevity-focused healthcare has led consumers to prioritize sustained energy levels, cognitive alertness, and active lifestyles rather than waiting for clinical issues to arise. As a result, products targeting energy and active aging benefit from higher adoption rates, consistent daily consumption, and broader applicability, which collectively drive their leading share in the global advanced therapeutics (aging and wellness) market.

Segmentation 3: By Distribution Channel

  • Retail
  • Online Marketplaces
  • Direct-to-Consumer
  • Others

Retail to Dominate the Advanced Therapeutics (Aging and Wellness) Market (by Distribution Channel)

In 2024, the retail segment accounted for the largest share of the global advanced therapeutics (aging and wellness) market. This is primarily due to strong consumer trust, especially among the aging population, and the importance of in-person guidance for product selection in health-related purchases. Additionally, the widespread presence of pharmacy and retail networks, coupled with immediate product availability and established purchasing habits, continues to drive higher volumes through this channel compared to digital and institutional alternatives.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • K.S.A.
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Advanced Therapeutics (Aging and Wellness) Market (by Region)

The global advanced therapeutics (aging and wellness) market (by region) has been dominated by North America, which held the largest share of the market in 2024 and is anticipated to retain its position in the market during the forecast period. This dominance is primarily driven by its highly developed healthcare and life sciences ecosystem, strong consumer awareness around preventive and longevity-focused health, and higher per capita healthcare expenditure compared to other regions. The U.S., in particular, acts as a global hub for innovation in aging science, with a high concentration of biotechnology companies, longevity startups, and nutraceutical players. Additionally, the region benefits from its strong adoption of premium, science-backed wellness solutions among aging populations, supported by favorable demographics, higher disposable incomes, and a cultural shift toward proactive health management.

Recent Developments in the Advanced Therapeutics (Aging and Wellness) Market

  • In December 2025, Amway Corp announced a five-year investment plan worth 2.1 billion yuan in China, including upgrades to its Guangzhou production base, digital infrastructure, R&D capabilities, and nationwide experience centers to strengthen its strategic operations in the market.
  • In November 2025, Orgain, LLC expanded its commercial reach by making select products available under Nestle Health Science contracts, GPOs, and distributor agreements to strengthen institutional distribution channels.
  • In October 2025, Amway Corp announced a $12 million investment in India over the next three to five years to expand experience-led physical stores, strengthen distributor capabilities, and enhance customer engagement in the market.
  • In September 2025, Orgain, LLC launched Organic Protein Powder + Metabolism Blend, a plant-based protein formulation enriched with prebiotic fiber, chromium, and botanical extracts to support energy, metabolism, digestion, and healthy weight management.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Aging-Driven Hormonal Decline and Metabolic Dysfunction Expand Demand for Healthy Aging Interventions: Rising life expectancy and age-related hormonal decline are driving metabolic dysfunction, including reduced muscle mass, increased adiposity, and higher risk of chronic diseases such as diabetes and cardiovascular conditions. As hormone replacement therapies face safety and efficacy limitations, demand is shifting toward nutrition-led and lifestyle-based interventions. This trend is expected to drive sustained growth in the aging and wellness market, particularly across muscle preservation and metabolic health solutions.

Market Restraints

Regulatory Fragmentation and Inconsistent Oversight across Geographies: Regulatory fragmentation across geographies creates significant inconsistencies in classification, compliance requirements, and health claim substantiation for nutrition-led aging and wellness products. This increases operational complexity, costs, and limits scalability while also constraining clinical credibility and healthcare integration. As a result, despite strong demand, the market remains largely consumer-driven, with harmonized regulatory frameworks needed for long-term growth and adoption.

Market Opportunities

Rising Demand for Sustainable and Plant-Derived Protein Solutions Creating Growth Opportunities across Aging and Active Populations: The growing shift toward plant-forward and sustainability-driven diets is expanding demand for plant-based protein and clean-label nutritional solutions, particularly among flexitarian consumers. Aging populations and active individuals are increasingly seeking digestible, ethically sourced, and functional protein alternatives to support muscle and metabolic health. This trend creates strong growth opportunities for manufacturers offering high-quality, bioavailable, and transparently sourced plant-derived formulations.

How can this report add value to an organization?

Product/Innovation Strategy: The global advanced therapeutics (aging and wellness) market has been divided into several key segments, including product type, application type, distribution channel, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Partnerships, alliances, fundings, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the global advanced therapeutics (aging and wellness) market.

Competitive Strategy: The global advanced therapeutics (aging and wellness) market consists of various public and a few private companies. Key players in advanced therapeutics (aging and wellness) market, analyzed and profiled in the study, involve established players that offer various kinds of products.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The market contribution of advanced therapeutics (aging and wellness) is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The scope of the report exclusively covers commercially available supplementation products positioned for muscle preservation, metabolic and weight management, energy and endurance enhancement, hormonal balance support, targeted micronutrient optimization, and therapeutic nutrition for age-associated health management.
  • The report excludes prescription pharmaceuticals indicated for disease treatment, investigational or non-commercialized regenerative and gene-based therapies, cosmetic- or aesthetic-positioned supplements, and pediatric-focused nutritional products. The market scope is limited to commercially available formulations intended for adult aging and wellness applications.

Primary Research

The primary sources involve industry experts from the global advanced therapeutics (aging and wellness) market and various stakeholders in the ecosystem. Respondents such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of reports, segmentation, and key qualitative findings
  • understanding the competitive landscape
  • validation of the numbers of various markets for the market type
  • percentage split of individual markets for geographical analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Abbott Laboratories
  • Archer-Daniels-Midland Company
  • Amway Corp
  • Gainful Inc.
  • Glanbia plc
  • Health and Happiness (H&H) International Holdings Limited
  • Herbalife Ltd.
  • Iovate Health Sciences International Inc.
  • Nar Labs, Inc.
  • Nestle S.A.
  • NOW Foods
  • Orgain, LLC
  • RBK Nutraceuticals Pty Ltd
  • Thorne HealthTech
  • Vitabiotics Ltd.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Product Benchmarking
  • 1.3 Regulatory Landscape/Compliances
    • 1.3.1 U.S.
    • 1.3.2 Europe
    • 1.3.3 Asia-Pacific
      • 1.3.3.1 China
      • 1.3.3.2 Japan
  • 1.4 Key Trends
    • 1.4.1 Structural Shift from Reactive Healthcare to Proactive Self-Care Supplementation
    • 1.4.2 Shift toward Advanced Delivery Technologies in Aging and Wellness Supplements
  • 1.5 Emerging Therapeutics for Aging and Wellness
  • 1.6 Market Dynamics
    • 1.6.1 Impact Analysis
    • 1.6.2 Market Drivers
      • 1.6.2.1 Aging-Driven Hormonal Decline and Metabolic Dysfunction Expand Demand for Healthy Aging Interventions
      • 1.6.2.2 Rising Global Burden of Obesity and Metabolic Disorders Drives Demand for Weight Management and Metabolic Nutrition Solutions
      • 1.6.2.3 Rising Emphasis on Muscle Mass Preservation and Physical Performance across Aging and Active Populations Drives Demand for Protein and Ergogenic Nutrition
    • 1.6.3 Market Restraints
      • 1.6.3.1 Regulatory Fragmentation and Inconsistent Oversight across Geographies
      • 1.6.3.2 Limited Consumer Literacy, Misinformation, and Self-Prescription Constrain Effective Adoption
    • 1.6.4 Market Opportunities
      • 1.6.4.1 Rising Demand for Sustainable and Plant-Derived Protein Solutions Creating Growth Opportunities across Aging and Active Populations
      • 1.6.4.2 Expanding Role of Nutrition-Led Interventions in Neurodegenerative and Cognitive Health Applications

2 Product Type

  • 2.1 Product Type Summary
  • 2.2 Active/Sports Nutrition
    • 2.2.1 Protein-Based Supplements
    • 2.2.2 Amino Acids and Recovery Supplements
    • 2.2.3 Performance and Energy Supplements
  • 2.3 Functional Nutrition
    • 2.3.1 Metabolic and Weight Management Supplements
    • 2.3.2 Hormonal Support Supplements
    • 2.3.3 Vitamins, Minerals, and Micronutrient Supplements
  • 2.4 Therapeutic Nutrition

3 Application Type

  • 3.1 Application Type Summary
  • 3.2 Muscle Strength, Mass, and Mobility Preservation
  • 3.3 Energy, Endurance, and Active Aging
  • 3.4 Weight Management and Metabolic Health
  • 3.5 Hormonal Balance Support
  • 3.6 Others

4 Distribution Channel

  • 4.1 Distribution Channel Summary
  • 4.2 Retail
  • 4.3 Online Marketplaces
  • 4.4 Direct-to-Consumer
  • 4.5 Others

5 Region

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 By Country
      • 5.2.4.1 U.S.
      • 5.2.4.2 Canada
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 By Country
      • 5.3.4.1 Germany
      • 5.3.4.2 U.K.
      • 5.3.4.3 France
      • 5.3.4.4 Italy
      • 5.3.4.5 Spain
      • 5.3.4.6 Rest-of-Europe
  • 5.4 Asia Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 By Country
      • 5.4.4.1 Japan
      • 5.4.4.2 China
      • 5.4.4.3 India
      • 5.4.4.4 Rest-of-Asia-Pacific
  • 5.5 Latin America
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 By Country
      • 5.5.4.1 Brazil
      • 5.5.4.2 Mexico
      • 5.5.4.3 Rest-of-Latin America
  • 5.6 Middle East and Africa
    • 5.6.1 Regional Overview
    • 5.6.2 Driving Factors for Market Growth
    • 5.6.3 Factors Challenging the Market
    • 5.6.4 By Country
      • 5.6.4.1 K.S.A.
      • 5.6.4.2 South Africa
      • 5.6.4.3 U.A.E.
      • 5.6.4.4 Rest-of-Middle East and Africa

6 Competitive Benchmarking & Company Profiles

  • 6.1 Key Strategies and Developments (by Company)
    • 6.1.1 Partnerships, Collaborations, and Business Expansions
    • 6.1.2 New Offerings
  • 6.2 Company Profiles
    • 6.2.1 Herbalife Ltd.
      • 6.2.1.1 Overview
      • 6.2.1.2 Top Products/Product Portfolio
      • 6.2.1.3 Top Competitors
      • 6.2.1.4 Target Customers
      • 6.2.1.5 Key Personnel
      • 6.2.1.6 Analyst View
    • 6.2.2 Glanbia plc
      • 6.2.2.1 Overview
      • 6.2.2.2 Top Products/Product Portfolio
      • 6.2.2.3 Top Competitors
      • 6.2.2.4 Target Customers
      • 6.2.2.5 Key Personnel
      • 6.2.2.6 Analyst View
    • 6.2.3 Health and Happiness (H&H) International Holdings Limited
      • 6.2.3.1 Overview
      • 6.2.3.2 Top Products/Product Portfolio
      • 6.2.3.3 Top Competitors
      • 6.2.3.4 Target Customers
      • 6.2.3.5 Key Personnel
      • 6.2.3.6 Analyst View
    • 6.2.4 Archer-Daniels-Midland Company
      • 6.2.4.1 Overview
      • 6.2.4.2 Top Products/Product Portfolio
      • 6.2.4.3 Top Competitors
      • 6.2.4.4 Target Customers
      • 6.2.4.5 Key Personnel
      • 6.2.4.6 Analyst View
    • 6.2.5 Abbott Laboratories
      • 6.2.5.1 Overview
      • 6.2.5.2 Top Products/Product Portfolio
      • 6.2.5.3 Top Competitors
      • 6.2.5.4 Target Customers
      • 6.2.5.5 Key Personnel
      • 6.2.5.6 Analyst View
    • 6.2.6 Nestle S.A. (Nestle Health Science)
      • 6.2.6.1 Overview
      • 6.2.6.2 Top Products/Product Portfolio
      • 6.2.6.3 Top Competitors
      • 6.2.6.4 Target Customers
      • 6.2.6.5 Key Personnel
      • 6.2.6.6 Analyst View
    • 6.2.7 Amway Corp
      • 6.2.7.1 Overview
      • 6.2.7.2 Top Products/Product Portfolio
      • 6.2.7.3 Top Competitors
      • 6.2.7.4 Target Customers
      • 6.2.7.5 Key Personnel
      • 6.2.7.6 Analyst View
    • 6.2.8 Gainful Inc.
      • 6.2.8.1 Overview
      • 6.2.8.2 Top Products/Product Portfolio
      • 6.2.8.3 Top Competitors
      • 6.2.8.4 Target Customers
      • 6.2.8.5 Key Personnel
      • 6.2.8.6 Analyst View
    • 6.2.9 Iovate Health Sciences International Inc.
      • 6.2.9.1 Overview
      • 6.2.9.2 Top Products/Product Portfolio
      • 6.2.9.3 Top Competitors
      • 6.2.9.4 Target Customers
      • 6.2.9.5 Key Personnel
      • 6.2.9.6 Analyst View
    • 6.2.10 Nar Labs, Inc.
      • 6.2.10.1 Overview
      • 6.2.10.2 Top Products/Product Portfolio
      • 6.2.10.3 Top Competitors
      • 6.2.10.4 Target Customers
      • 6.2.10.5 Key Personnel
      • 6.2.10.6 Analyst View
    • 6.2.11 Vitabiotics Ltd.
      • 6.2.11.1 Overview
      • 6.2.11.2 Top Products/Product Portfolio
      • 6.2.11.3 Top Competitors
      • 6.2.11.4 Target Customers
      • 6.2.11.5 Key Personnel
      • 6.2.11.6 Analyst View
    • 6.2.12 Thorne HealthTech
      • 6.2.12.1 Overview
      • 6.2.12.2 Top Products/Product Portfolio
      • 6.2.12.3 Top Competitors
      • 6.2.12.4 Target Customers
      • 6.2.12.5 Key Personnel
      • 6.2.12.6 Analyst View
    • 6.2.13 NOW Foods
      • 6.2.13.1 Overview
      • 6.2.13.2 Top Products/Product Portfolio
      • 6.2.13.3 Top Competitors
      • 6.2.13.4 Target Customers
      • 6.2.13.5 Key Personnel
      • 6.2.13.6 Analyst View
    • 6.2.14 RBK Nutraceuticals Pty Ltd
      • 6.2.14.1 Overview
      • 6.2.14.2 Top Products/Product Portfolio
      • 6.2.14.3 Top Competitors
      • 6.2.14.4 Target Customers
      • 6.2.14.5 Key Personnel
      • 6.2.14.6 Analyst View
    • 6.2.15 Elysium Health
      • 6.2.15.1 Overview
      • 6.2.15.2 Top Products/Product Portfolio
      • 6.2.15.3 Top Competitors
      • 6.2.15.4 Target Customers
      • 6.2.15.5 Key Personnel
      • 6.2.15.6 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Advanced Therapeutics (Aging and Wellness) Market (by Scenario), $Billion, 2024, 2030, and 2035
  • Figure 2: Global Advanced Therapeutics (Aging and Wellness) Market (by Region), $Billion, 2024, 2030, and 2035
  • Figure 3: Global Advanced Therapeutics (Aging and Wellness) Market (by Product Type), $Billion, 2024, 2030, and 2035
  • Figure 4: Global Advanced Therapeutics (Aging and Wellness) Market (by Application Type), $Billion, 2024, 2030, and 2035
  • Figure 5: Global Advanced Therapeutics (Aging and Wellness) Market (by Distribution Channel), $Billion, 2024, 2030, and 2035
  • Figure 6: Global Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 7: Aging-Related Influence on Metabolism
  • Figure 8: Global Advanced Therapeutics (Aging and Wellness) Market (by Product Type), $Billion, 2024, 2030, and 2035
  • Figure 9: Global Advanced Therapeutics (Aging and Wellness) Market (Active/Sports Nutrition), $Billion, 2024-2035
  • Figure 10: Global Advanced Therapeutics (Aging and Wellness) Market (Protein-Based Supplements), $Billion, 2024-2035
  • Figure 11: Global Advanced Therapeutics (Aging and Wellness) Market (Amino Acids and Recovery Supplements), $Billion, 2024-2035
  • Figure 12: Global Advanced Therapeutics (Aging and Wellness) Market (Performance and Energy Supplements), $Billion, 2024-2035
  • Figure 13: Global Advanced Therapeutics (Aging and Wellness) Market (Functional Nutrition), $Billion, 2024-2035
  • Figure 14: Global Advanced Therapeutics (Aging and Wellness) Market (Metabolic and Weight Management Supplements), $Billion, 2024-2035
  • Figure 15: Global Advanced Therapeutics (Aging and Wellness) Market (Hormonal Support Supplements), $Billion, 2024-2035
  • Figure 16: Global Advanced Therapeutics (Aging and Wellness) Market (Vitamins, Minerals, and Micronutrient Supplements), $Billion, 2024-2035
  • Figure 17: Global Advanced Therapeutics (Aging and Wellness) Market (Therapeutic Nutrition), $Billion, 2024-2035
  • Figure 18: Global Advanced Therapeutics (Aging and Wellness) Market (by Application Type), $Billion, 2024, 2030, and 2035
  • Figure 19: Global Advanced Therapeutics (Aging and Wellness) Market (Muscle Strength, Mass, and Mobility Preservation), $Billion, 2024-2035
  • Figure 20: Global Advanced Therapeutics (Aging and Wellness) Market (Energy, Endurance, and Active Aging), $Billion, 2024-2035
  • Figure 21: Global Advanced Therapeutics (Aging and Wellness) Market (Weight Management and Metabolic Health), $Billion, 2024-2035
  • Figure 22: Global Advanced Therapeutics (Aging and Wellness) Market (Hormonal Balance Support), $Billion, 2024-2035
  • Figure 23: Global Advanced Therapeutics (Aging and Wellness) Market (Others), $Billion, 2024-2035
  • Figure 24: Global Advanced Therapeutics (Aging and Wellness) Market (by Distribution Channel), $Billion, 2024-2035
  • Figure 25: Global Advanced Therapeutics (Aging and Wellness) Market (Retail), $Billion, 2024-2035
  • Figure 26: Global Advanced Therapeutics (Aging and Wellness) Market (Online Marketplaces), $Billion, 2024-2035
  • Figure 27: Global Advanced Therapeutics (Aging and Wellness) Market (Direct-to-Consumer), $Billion, 2024-2035
  • Figure 28: Global Advanced Therapeutics (Aging and Wellness) Market (Others), $Billion, 2024-2035
  • Figure 29: North America Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 30: U.S. Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 31: Canada Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 32: Europe Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 33: Germany Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 34: U.K. Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 35: France Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 36: Italy Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 37: Spain Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 38: Rest-of-Europe Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 39: Asia Pacific Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 40: Japan Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 41: China Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 42: India Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 43: Rest-of-Asia-Pacific Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 44: Latin America Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 45: Brazil Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 46: Mexico Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 47: Rest-of-Latin America Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 48: Middle East and Africa Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 49: K.S.A. Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 50: South Africa Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 51: U.A.E Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 52: Rest-of-Middle East and Africa Advanced Therapeutics (Aging and Wellness) Market, $Billion, 2024-2035
  • Figure 53: Data Triangulation
  • Figure 54: Top-Down and Bottom-Up Approach
  • Figure 55: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Advanced Therapeutics (Aging and Wellness) Market, Product Benchmarking
  • Table 3: Impact Analysis of Market Dynamics, 2024-2035
  • Table 4: Potential Age-Related Metabolic Consequences of Reduced Hormones